Clinical Trials Update: Sept. 14, 2006
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
548270
The findings of the 'American-Australian-African trial with DronedarONe In atrial fibrillation or flutter patients for the maintenance of Sinus rhythm' (ADONIS) trial, announced at the annual meeting of the ...
34476
MONDAY, July 2 (HealthDay News) -- New research may someday provide another treatment option for patients battling deadly pancreatic cancer.
138698
Another schizophrenia drug from the company shows promise in a clinical trial.
388692
roundup Plus: PeopleSoft-Oracle trial delayed...IBM, Boeing team up for defense work...TI touts combo chip with VoIP, Wi-Fi...ContextWeb nabs $3 million.
38677
The world's biggest drug makers unveiled  plans on Thursday to publish more data about clinical trials of  their medicines in a bid to reassure patients about their  safety.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
25501
(December 29, 2004) - Six clinical studies at the University of Rochester Medical Center have ended because of findings that question the safety of the drugs under investigation.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
589264
Panacos releases more clinical trial results for an exciting drug.
273621
Pfizer Inc&#39;s experimental oral  biotechnology drug axitinib demonstrated substantial anti-tumor  activity in patients with advanced thyroid cancer in a small,  mid-stage clinical trial, according to data released at a major  cancer meeting on Saturday.
443950
October 1, 2004 5:11 PM GMT (Datamonitor) - The Food and Drug Administration (FDA) is set to examine the potential link between antidepressants and increased suicidal tendencies in adults.
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
535175
BioSante releases more info on the pivotal studies for its lead drug.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
456511
Compiled by PAUL MONTELLA Sept. 19